Skip to main content
PMC home page
The Journal of Physiology logoLink to The Journal of Physiology
. 1991 Dec;444:289–302. doi: 10.1113/jphysiol.1991.sp018878

Effects of neuropeptide-Y on renal function and its interaction with sympathetic stimulation in conscious dogs.

P B Persson 1, H Ehmke 1, B Nafz 1, R Lang 1, E Hackenthal 1, R Nobiling 1, M S Dietrich 1, H R Kirchheim 1
PMCID: PMC1179933  PMID: 1688030

Abstract

1. The effects of neuropeptide-Y (NPY) on renal function were investigated in conscious foxhounds. 2. Dose-response curves (n = 7) were obtained for NPY by measuring renal blood flow (RBF), glomerular filtration rate (GFR), urine excretion (VU), sodium excretion (VNa), potassium excretion (VK) and plasma renin activity (PRA) at different infusion rates. All variables decreased with increasing infusion rates except for PRA, which surprisingly did not change during the different infusion rates. 3. The influence of the non-constrictor dose of NPY at control pressure, and after servo-controlling renal arterial pressure at 80 mmHg, was determined for these parameters (n = 6). 4. This was repeated during a reflex sympathetic activation via carotid sinus hypotension, in order to quantify a possible interaction between the sympathetic transmitter and co-transmitter (n = 6). 5. The subthreshold NPY dose raised plasma NPY-like immunoreactivity (NPY-LI IR) significantly (renal venous plasma: 54 +/- 13 vs. 405 +/- 117 pg ml-1; P less than 0.05) and enhanced the pressure-dependent (80 mmHg) antidiuresis (0.48 +/- 0.06 vs. 0.24 +/- 0.02 ml min-1; P less than 0.05), antinatriuresis (46 +/- 11 vs. 25 +/- 3 mumol min-1; P less than 0.05), antikaliuresis (19 +/- 4 vs. 9 +/- 0.7 mumol min-1; P less than 0.05) and pressure-dependent renin release (0.95 +/- 0.27 vs. 3.0 +/- 1.1 ng angiotensin I ml-1 h-1; P less than 0.05). These effects are consistent with a non-uniform vasoconstrictor action of NPY in the renal vascular bed (see accompanying papers). 6. The effects of NPY plus sympathetic activation were less than the sum of the two individual effects, which may rely on a presynaptic mechanism.

Full text

PDF
289

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen J. M., Godfrey N. P., Yeats J. C., Bing R. F., Bloom S. R. Neuropeptide Y in renovascular models of hypertension in the rat. Clin Sci (Lond) 1986 May;70(5):485–488. doi: 10.1042/cs0700485. [DOI] [PubMed] [Google Scholar]
  2. Allen J. M., Raine A. E., Ledingham J. G., Bloom S. R. Neuropeptide Y: a novel renal peptide with vasoconstrictor and natriuretic activity. Clin Sci (Lond) 1985 Apr;68(4):373–377. doi: 10.1042/cs0680373. [DOI] [PubMed] [Google Scholar]
  3. Aubert J. F., Burnier M., Waeber B., Nussberger J., Dipette D. J., Burris J. F., Brunner H. R. Effects of a nonpressor dose of neuropeptide Y on cardiac output, regional blood flow distribution and plasma renin, vasopressin and catecholamine levels. J Pharmacol Exp Ther. 1988 Mar;244(3):1109–1115. [PubMed] [Google Scholar]
  4. Ballesta J., Lawson J. A., Pals D. T., Ludens J. H., Lee Y. C., Bloom S. R., Polak J. M. Significant depletion of NPY in the innervation of the rat mesenteric, renal arteries and kidneys in experimentally (aorta coarctation) induced hypertension. Histochemistry. 1987;87(3):273–278. doi: 10.1007/BF00492421. [DOI] [PubMed] [Google Scholar]
  5. Ballesta J., Polak J. M., Allen J. M., Bloom S. R. The nerves of the juxtaglomerular apparatus of man and other mammals contain the potent peptide NPY. Histochemistry. 1984;80(5):483–485. doi: 10.1007/BF00495438. [DOI] [PubMed] [Google Scholar]
  6. Corder R., Vallotton M. B., Lowry P. J., Ramage A. G. Neuropeptide Y lowers plasma renin activity in the anaesthetised cat. Neuropeptides. 1989 Aug-Sep;14(2):111–114. doi: 10.1016/0143-4179(89)90067-x. [DOI] [PubMed] [Google Scholar]
  7. Cox H. M., Cuthbert A. W., Håkanson R., Wahlestedt C. The effect of neuropeptide Y and peptide YY on electrogenic ion transport in rat intestinal epithelia. J Physiol. 1988 Apr;398:65–80. doi: 10.1113/jphysiol.1988.sp017029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cox H. M., Cuthbert A. W. Neuropeptide Y antagonises secretagogue evoked chloride transport in rat jejunal epithelium. Pflugers Arch. 1988 Nov;413(1):38–42. doi: 10.1007/BF00581226. [DOI] [PubMed] [Google Scholar]
  9. Dietrich M. S., Fretschner M., Nobiling R., Persson P. B., Steinhausen M. Renovascular effects of neuropeptide-Y in the split hydronephrotic rat kidney: non-uniform pattern of vascular reactivity. J Physiol. 1991 Dec;444:303–315. doi: 10.1113/jphysiol.1991.sp018879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Echtenkamp S. F., Dandridge P. F. Renal actions of neuropeptide Y in the primate. Am J Physiol. 1989 Apr;256(4 Pt 2):F524–F531. doi: 10.1152/ajprenal.1989.256.4.F524. [DOI] [PubMed] [Google Scholar]
  11. Ehmke H., Persson P. B., Seyfarth M., Kirchheim H. R. Neurogenic control of pressure natriuresis in conscious dogs. Am J Physiol. 1990 Sep;259(3 Pt 2):F466–F473. doi: 10.1152/ajprenal.1990.259.3.F466. [DOI] [PubMed] [Google Scholar]
  12. Ehmke H., Persson P., Fischer S., Hackenthal E., Kirchheim H. Resetting of pressure-dependent renin release by intrarenal alpha 1-adrenoceptors in conscious dogs. Pflugers Arch. 1989 Jan;413(3):261–266. doi: 10.1007/BF00583539. [DOI] [PubMed] [Google Scholar]
  13. Hackenthal E., Aktories K., Jakobs K. H., Lang R. E. Neuropeptide Y inhibits renin release by a pertussis toxin-sensitive mechanism. Am J Physiol. 1987 Mar;252(3 Pt 2):F543–F550. doi: 10.1152/ajprenal.1987.252.3.F543. [DOI] [PubMed] [Google Scholar]
  14. Knight D. S., Fabre R. D., Beal J. A. Identification of noradrenergic nerve terminals immunoreactive for neuropeptide Y and vasoactive intestinal peptide in the rat kidney. Am J Anat. 1989 Mar;184(3):190–204. doi: 10.1002/aja.1001840303. [DOI] [PubMed] [Google Scholar]
  15. Leys K., Schachter M., Sever P. Autoradiographic localisation of NPY receptors in rabbit kidney: comparison with rat, guinea-pig and human. Eur J Pharmacol. 1987 Feb 10;134(2):233–237. doi: 10.1016/0014-2999(87)90171-3. [DOI] [PubMed] [Google Scholar]
  16. Linton-Dahlöf P. Modulatory interactions of neuropeptide Y (NPY) on sympathetic neurotransmission. Acta Physiol Scand Suppl. 1989;586:1–85. [PubMed] [Google Scholar]
  17. Lundberg J. M., Pernow J., Tatemoto K., Dahlöf C. Pre- and postjunctional effects of NPY on sympathetic control of rat femoral artery. Acta Physiol Scand. 1985 Apr;123(4):511–513. doi: 10.1111/j.1748-1716.1985.tb07619.x. [DOI] [PubMed] [Google Scholar]
  18. Minson R., McRitchie R., Chalmers J. Effects of neuropeptide Y on the renal, mesenteric and hindlimb vascular beds of the conscious rabbit. J Auton Nerv Syst. 1989 Jul;27(2):139–146. doi: 10.1016/0165-1838(89)90095-7. [DOI] [PubMed] [Google Scholar]
  19. Nobiling R., Gabel M., Persson P. B., Dietrich M. S., Bührle C. P. Differential effect of neuropeptide-Y on membrane potential of cells in renal arterioles of the hydronephrotic mouse. J Physiol. 1991 Dec;444:317–327. doi: 10.1113/jphysiol.1991.sp018880. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Pernow J., Lundberg J. M. Modulation of noradrenaline and neuropeptide Y (NPY) release in the pig kidney in vivo: involvement of alpha 2, NPY and angiotensin II receptors. Naunyn Schmiedebergs Arch Pharmacol. 1989 Oct;340(4):379–385. doi: 10.1007/BF00167038. [DOI] [PubMed] [Google Scholar]
  21. Persson P. B., Ehmke H., Kögler U., Kirchheim H. Modulation of natriuresis by sympathetic nerves and angiotensin II in conscious dogs. Am J Physiol. 1989 Mar;256(3 Pt 2):F485–F489. doi: 10.1152/ajprenal.1989.256.3.F485. [DOI] [PubMed] [Google Scholar]
  22. Persson P. B., Ehmke H., Nafz B., Kirchheim H. R. Resetting of renal autoregulation in conscious dogs: angiotensin II and alpha1-adrenoceptors. Pflugers Arch. 1990 Sep;417(1):42–47. doi: 10.1007/BF00370767. [DOI] [PubMed] [Google Scholar]
  23. Persson P. B., Ehmke H., Nafz B., Kirchheim H. R. Sympathetic modulation of renal autoregulation by carotid occlusion in conscious dogs. Am J Physiol. 1990 Feb;258(2 Pt 2):F364–F370. doi: 10.1152/ajprenal.1990.258.2.F364. [DOI] [PubMed] [Google Scholar]
  24. Reinecke M., Forssmann W. G. Neuropeptide (neuropeptide Y, neurotensin, vasoactive intestinal polypeptide, substance P, calcitonin gene-related peptide, somatostatin) immunohistochemistry and ultrastructure of renal nerves. Histochemistry. 1988;89(1):1–9. doi: 10.1007/BF00496578. [DOI] [PubMed] [Google Scholar]
  25. Schachter M., Miles C. M., Leys K., Sever P. S. Characterization of neuropeptide Y receptors in rabbit kidney: preliminary comparisons with rat and human kidney. J Cardiovasc Pharmacol. 1987;10 (Suppl 12):S157–S162. [PubMed] [Google Scholar]
  26. Waeber B., Evéquoz D., Aubert J. F., Flückiger J. P., Juillerat L., Nussberger J., Brunner H. R. Prevention of renal hypertension in the rat by neuropeptide Y. J Hypertens. 1990 Jan;8(1):21–25. doi: 10.1097/00004872-199001000-00005. [DOI] [PubMed] [Google Scholar]
  27. Wahlestedt C., Edvinsson L., Ekblad E., Håkanson R. Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action. J Pharmacol Exp Ther. 1985 Sep;234(3):735–741. [PubMed] [Google Scholar]
  28. Wahlestedt C., Håkanson R., Vaz C. A., Zukowska-Grojec Z. Norepinephrine and neuropeptide Y: vasoconstrictor cooperation in vivo and in vitro. Am J Physiol. 1990 Mar;258(3 Pt 2):R736–R742. doi: 10.1152/ajpregu.1990.258.3.R736. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Physiology are provided here courtesy of The Physiological Society

RESOURCES